FindTrial
Sign In

The effect of methyltransferase Mettl4 in atherosclerosis development

The effect of methyltransferase Mettl4 in atherosclerosis development

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071451
Enrollment
Unknown
Registered
2023-05-16
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Interventions

Non-atherosclerosis group (Group C. Peripheral venous blood and vascular tissue were extracted):None
Atherosclerosis group (Group S. Peripheral venous blood and vascular tissue were extracted):None

Sponsors

Sir Run Run Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who signed informed consent; 2. Patients with complete clinical records; 3. American Society of Anesthesiologists (ASA) Anesthesia Risk Rating I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with lung, liver, kidney, blood and other important system diseases; 2. Patients with communication or cognitive impairment; 3. Patients with symptoms of respiratory infection; 4. Abnormal electrocardiogram.

Design outcomes

Primary

MeasureTime frame
Mettl4 expression level;—

Countries

China

Contacts

Public Contactzheng longbin

Sir Run Run Hospital, Nanjing Medical University

zhenglongbin1988@126.com+86 180 6175 0597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026